Challenges and strategies for recruitment of minorities to clinical research and trials.
Susan P Fisher-HochJennifer E BelowKari E NorthJoseph B McCormickPublished in: Journal of clinical and translational science (2023)
Minority populations are largely absent from clinical research trials. The neglect of these populations has become increasingly apparent, with escalating cancer burdens and chronic disease. The challenges to recruitment of minorities in the United States are multiple including trust or lack thereof. Keys to successful recruitment are responding to community issues, its history, beliefs, and its social and economic pressures. The strategy we have used in many low-income, sometimes remote, communities is to recruit staff from the same community and train them in the required basic research methods. They are the first line of communication. After our arrival in the Texas Rio Grande Valley in 2001, we applied these principles learned over years of global research, to studies of chronic diseases. Beginning in 2004, we recruited and trained a team of local women who enrolled in a cohort of over five thousand Mexican Americans from randomly selected households. This cohort is being followed, and the team has remained, acquiring not only advanced skills (ultrasound, FibroScan, retinal photos, measures of cognition, etc.) but capacity to derive key health information. Currently, we are participating in multiple funded studies, including an NIH clinical trial, liver disease, obesity, and diabetes using multiomics aimed at developing precision medicine approaches to chronic disease prevention and treatment.
Keyphrases
- health information
- healthcare
- mental health
- clinical trial
- type diabetes
- social media
- palliative care
- papillary thyroid
- case control
- polycystic ovary syndrome
- cardiovascular disease
- metabolic syndrome
- insulin resistance
- weight loss
- magnetic resonance imaging
- optical coherence tomography
- genetic diversity
- squamous cell
- weight gain
- randomized controlled trial
- lymph node metastasis
- mild cognitive impairment
- mass spectrometry
- ultrasound guided
- combination therapy
- adipose tissue
- double blind
- contrast enhanced ultrasound
- childhood cancer
- placebo controlled